ROZOV YADIN purchased 424.2% of their position (70K shares) of ORAMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $141.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/15/2023ACC: 0001209191-23-018944
+70K
Net shares
Net buyer
$141.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
70K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$1.96
Trade value
$39.12K
% of position
121.2%
3/13/2023
16.50K→36.50K
Common Stock
Direct
Shares
+50K
Price / share
$2.05
Trade value
$102.45K
% of position
137.0%
3/14/2023
36.50K→86.50K
Total
Net shares
+70K
Net value
$141.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2023 | P · Purchase | +20K | $1.96 | $39.12K | 121.2% | 16.50K | 36.50K |
| Common Stock Direct | 3/14/2023 | P · Purchase | +50K | $2.05 | $102.45K | 137.0% | 36.50K | 86.50K |
| Total | +70K | $141.57K | ||||||
Derivative Transactions0
No derivative transactions reported